DEXA Scan Age Recommendations
All women should begin routine DEXA screening at age 65 years and all men at age 70 years, regardless of risk factors. 1, 2
Standard Screening Ages by Sex
Women
- Routine screening begins at age 65 years for all women, with no additional risk factors required 1, 2
- Screening is NOT recommended for women younger than 65 years without documented risk factors 1, 2
Men
- Routine screening begins at age 70 years for all men, regardless of risk factors 1, 2
- Screening is NOT recommended for men younger than 70 years without documented risk factors 1, 2
Earlier Screening for High-Risk Individuals (Any Age)
The following conditions justify DEXA screening before the standard age cutoffs:
Previous Fracture History
- Any adult with a previous fragility fracture should undergo immediate DEXA screening, regardless of age 1, 3
- The presence of any prevalent fracture increases future fracture risk by approximately 2-fold or more 4
Medication-Related Risk Factors
- Individuals receiving or expected to receive glucocorticoid therapy for >3 months require DEXA screening 5, 1
- Glucocorticoid-induced osteoporosis causes fractures at higher BMD levels than postmenopausal osteoporosis (treatment threshold T-score of -1.5 rather than -2.5) 6
- Individuals on androgen deprivation therapy for prostate cancer 5, 1
- Individuals on aromatase inhibitor therapy 5
- Individuals on chronic anticonvulsant drugs or chronic heparin therapy 5
Endocrine and Metabolic Conditions
- Hypogonadal men >18 years of age and men with surgically or chemotherapeutically induced castration 5
- Individuals with hyperparathyroidism, hyperthyroidism, or Cushing syndrome 5
- Postmenopausal women under 65 with early menopause 2
Other Medical Conditions
- Chronic alcoholism or established cirrhosis 5, 3
- Rheumatoid arthritis or other chronic inflammatory arthritides 5
- Eating disorders including anorexia nervosa and bulimia 5
- Organ transplantation 5
- Spinal cord injury (screen as soon as medically stable) 1, 3
- Gastrointestinal malabsorption, malnutrition, sprue, or vitamin D deficiency 5
- Prolonged immobilization 5
Clinical Risk Assessment for Postmenopausal Women Under 65
- Postmenopausal women under 65 with 10-year major osteoporotic fracture risk ≥9.3% as calculated by FRAX should undergo DEXA screening 1, 2
- Body weight less than 127 pounds (approximately 58 kg) 2
- Parental history of hip fracture 2
Screening Intervals After Initial DEXA
Normal or Mild Osteopenia
- Repeat DEXA in 2-3 years for individuals with normal bone density or mild osteopenia 1, 2
- For individuals with normal baseline BMD (T-score ≥-1) and no major risk factors, serial BMD measurements every 24 months are not necessary, as progression to treatment threshold takes approximately 16 years 4
Osteoporosis or On Treatment
- Repeat DEXA in 1-2 years for individuals with osteoporosis or on treatment to monitor treatment effectiveness 1, 2
High-Risk for Accelerated Bone Loss
- Repeat DEXA in 1-2 years for individuals at high risk for accelerated bone loss (glucocorticoid therapy, spinal cord injury) 5, 1
Critical Pitfalls to Avoid
Age-Related Errors
- Do not screen women under 65 or men under 70 without documented risk factors - this exposes patients to unnecessary radiation and costs without clinical benefit 2
- Do not delay screening in patients with chronic alcoholism, early menopause, or glucocorticoid use - these conditions justify earlier screening regardless of age 2, 3
Interval-Related Errors
- Never repeat DEXA at intervals less than 1 year under any circumstances 1
- Do not repeat DEXA scans more frequently than every 2 years in patients with normal BMD - testing precision limitations make shorter intervals unreliable and clinically meaningless 1, 2
- A minimum of 2 years is needed to reliably measure a change in BMD due to limitations in testing precision 1
Risk Assessment Errors
- Do not assume obesity provides adequate protection against osteoporosis when other major risk factors are present 3
- Higher body weight is actually protective against osteoporosis, not an indication for screening 3
- Do not overlook men after fractures - men account for 24% of hip fractures and 21% of wrist fractures but only receive 10% of BMD tests 4
Scan Technique
- Scan both lumbar spine and bilateral hips in all patients 5, 2
- Use T-scores for all postmenopausal women regardless of age 2
- Use Z-scores for premenopausal women and men under 50 2
- **Consider Vertebral Fracture Assessment (VFA) during the same session for patients with T-score <-1.0 and one or more of the following:** women ≥70 years or men ≥80 years, historical height loss >4 cm, self-reported prior vertebral fracture, or glucocorticoid therapy ≥5 mg prednisone daily for ≥3 months 5, 1